A Prospective, International Phase 2 Study of Bortezomib Retreatment in Patients with Relapsed Multiple Myeloma
AuthID
P-002-06Z
P-002-06Z
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service